HU
$401.54
-4.98
(-1.23%)
As of Sep 5, 2026, 2:46 PM EDT · cached
Price history
Humana (HUM) is trading down at $401.54 (-1.23%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.
Recent News (20)
-
CNC, UNH, CVS, HUM Stocks Slip After-Hours — Trump Administration Reportedly Seeks To Scrap Subsidies On Certain Medicare Plans CNC, UNH, CVS, HUM Stocks Slip After-Hours — Trump Administration Reportedly Seeks To Scrap Subsidies On Certain Medicare Plans Stocktwits
-
UNH, HUM, CNC Stocks Rally On Medicare Advantage Rate Surprise UNH, HUM, CNC Stocks Rally On Medicare Advantage Rate Surprise Stocktwits
-
UNH Vs. HUM: Which Insurer Stock Has More Upside After CMS Reverses Wall Street’s Biggest Medicare Rate Fear? UNH Vs. HUM: Which Insurer Stock Has More Upside After CMS Reverses Wall Street’s Biggest Medicare Rate Fear? Stocktwits
-
-
Cantor Fitzgerald reiterates Humana stock rating at Neutral
Cantor Fitzgerald reiterates Humana stock rating at Neutral
-
Can Better Star Ratings and Margin Expansion Drive Humana (HUM) Higher?
Can Better Star Ratings and Margin Expansion Drive Humana (HUM) Higher?
-
Thyme Care Closes $125+ Million Series E, Establishes Thyme Companies to Broaden Its Impact Across the Oncology Ecosystem Morgan Health, CVS Health Ventures, and Humana, alongside other strategic payers and providers, invest in Thyme Care at a valuation of more than $2B The new capital accelerates Thyme Care's continued …
-
Humana Is Cutting Medicare Advantage Plans for 2027. The Non-Renewal Letters Arrive in Early October.
Humana Is Cutting Medicare Advantage Plans for 2027. The Non-Renewal Letters Arrive in Early October.
-
HUM Nutrition Launches Stack & Sculpt™, a Peptide-Powered Creatine for Toning Introducing Advanced Toning Technology™. This refreshing formula pairs 5g of creatine monohydrate with 2.4g of clinically studied PeptiStrong® from Nuritas, bringing HUM's clean and clinical approach …
-
Humana-owned Villages Health agrees to $542M settlement for overbilling Medicare Humana-owned Villages Health agrees to $542M settlement for overbilling Medicare
-
Wolfe Research raises Humana stock price target to $450 on margin outlook
Wolfe Research raises Humana stock price target to $450 on margin outlook
-
Humana names Shantanu Nundy as chief medical officer
Humana names Shantanu Nundy as chief medical officer
-
-
Do Wall Street Analysts Like Humana Stock?
Do Wall Street Analysts Like Humana Stock?
-
-
Can Humana Improve Caregiver Retention With HealthStream Deal? Can Humana Improve Caregiver Retention With HealthStream Deal? The Globe and Mail
-
Humana stock (HUM) climbs 3% as 2027 COLA calculations obscure rising medical-cost shortfall Humana stock (HUM) climbs 3% as 2027 COLA calculations obscure rising medical-cost shortfall TechStock²
-
Glenmark’s U.S. unit settles Humana antitrust case for $15.3 mln
Glenmark’s U.S. unit settles Humana antitrust case for $15.3 mln
-
Humana appoints James Holland to lead Medicaid business
Humana appoints James Holland to lead Medicaid business
-
Morgan Stanley upgrades Humana stock rating on 2028 margin confidence
Morgan Stanley upgrades Humana stock rating on 2028 margin confidence
More Health Care stocks
- CNC Centene Corporation
- ELV Elevance Health
- UNH UnitedHealth Group
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- AMGN Amgen